NCT05702229 2026-03-18
Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
AstraZeneca
Phase 2 Recruiting
Clinical Trials
12 trialsNCT07468630 2026-03-12
TRIUNITE-08
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Phase 2 Recruiting
NCT07448142 2026-03-04
Low-Dose Radiotherapy to Sensitize Pucotenlimab Plus CAPEOX for pMMR Locally Advanced Rectal Cancer
Sun Yat-sen University
Phase 2 Recruiting
NCT07108127 2025-08-06
NePHera
Peking Union Medical College Hospital
Phase 2 Recruiting
NCT06808412 2025-02-05
To Explore the Efficacy of Sintilimab Combined with Bevacizumab in Rectal Cancer
Xijing Hospital of Digestive Diseases
Phase 2 Recruiting
NCT06475352 2025-01-27
FUDOSE
UNICANCER
Phase 2 Recruiting
NCT06242418 2024-12-12
REVISE
West China Hospital
Phase 2 Recruiting
NCT06506292 2024-07-17
A Phase II Trial of Perioperative Adebrelimab Combined With XELOX in Resectable Locally Advanced Gastric/Gastroesophageal Junction Cancer (GC/GEJC)
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Recruiting
NCT03714490 2024-05-29
SUNRISE
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Recruiting
NCT06023758 2024-05-10
Phase 2 Trial of KN026+KN046±XELOX in HER2-positive Locally Advanced GC
Peking University
Phase 2 Recruiting
NCT05228431 2024-04-22
Modified Sandwich Therapeutic Regimen for Locally Advanced Rectal Cancer
Sun Yat-sen University
Phase 2 Recruiting
NCT05494060 2023-11-07
EXPLORING
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Recruiting